4//SEC Filing
LUND-JURGENSEN KIRSTEN 4
Accession 0001225208-18-004459
CIK 0000078003other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:38 PM ET
Size
13.1 KB
Accession
0001225208-18-004459
Insider Transaction Report
Form 4
PFIZER INCPFE
LUND-JURGENSEN KIRSTEN
Executive Vice President
Transactions
- Sale
Common Stock
2018-02-26$37.19/sh−9,510$353,677→ 17,770 total - Exercise/Conversion
Common Stock
2018-02-24$18.90/sh+15,957$301,587→ 36,959 total - Tax Payment
Common Stock
2018-02-24$36.26/sh−3,692$133,872→ 33,267 total - Tax Payment
Common Stock
2018-02-24$35.98/sh−5,091$183,174→ 28,176 total - Tax Payment
Common Stock
2018-02-26$37.09/sh−896$33,233→ 27,280 total - Exercise/Conversion
Stock Appreciation Rights
2018-02-24−15,957→ 0 totalExercise: $18.90From: 2018-02-24Exp: 2018-02-24→ Common Stock (15,957 underlying)
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 23, 2018
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- [F6]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001693493
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 7:38 PM ET
- Size
- 13.1 KB